Represented by a delegation led by Dangerous Drugs Board Permanent Member – Undersecretary Armando Ramolete, the Philippines joined the 19th ASEAN Drug Monitoring Network (ADMN) Meeting in Bangkok, Thailand, affirming its commitment to evidence-based, collaborative drug policy action in the region. The joint participation of the Dangerous Drugs Board (DDB) and the Philippine Drug Enforcement Agency (PDEA) marks a strategic effort to amplify the Philippines’ leadership in integrated drug monitoring and prevention.
In its presentation, the Philippine delegation delivered a comprehensive country report capturing the latest trends in the national drug situation, including high-value seizures, strengthened enforcement metrics, and the rising threat of new psychoactive substances. A key highlight was the government’s focus on social reintegration, digital innovations, and community-based responses, underscored by successful deployments of information systems which support transparency and data-informed interventions at the local government level.
Beyond enforcement, the Philippines emphasized its preventive education and cross-sectoral initiatives—from youth camps and peer-based programs to national forums engaging the judiciary, health institutions, and indigenous communities.
The ADMN serves as a strategic mechanism for ASEAN to foster early warning systems and share best practices in addressing emerging drug threats. As new substances and trafficking methods evolve, the Philippines remains a proactive contributor to building a safer, healthier, and drug-resilient ASEAN community.
